Burcon begins Puratein C production at Galesburg

Executive Summary

• Burcon NutraScience Corp. has commenced commercial production of Puratein C, a high-purity canola protein isolate, at its Galesburg facility.
• The product is available for immediate delivery to customers, marking a significant milestone in the company's strategy to scale revenue and expand its portfolio of next-generation plant proteins.
• Puratein C is derived from non-GMO, North American-grown canola seeds and is designed for use in food, beverage, foodservice, nutrition, and nutraceutical applications.

Key Details

• Product: Puratein C, a 90-per-cent-plus high-purity canola protein isolate.
• Facility: Galesburg facility.
• Status: Commercial production has begun; available for immediate delivery.
• Source Material: Extracted from non-genetically modified, North American-grown canola seeds using a process that upcycles byproducts from solvent-free canola oilseed processing.
• Product Specifications:
  • Protein content: Over 90 percent.
  • Amino Acid Profile: Complete, including all nine essential amino acids.
  • PDCAAS (Protein Digestibility-Corrected Amino Acid Score): 1.
  • Physical Properties: High solubility, light cream color, mild flavor profile.
• Target Applications: Dairy alternatives, ready-to-drink beverages, meat analogues, sauces, baked goods, foodservice, nutrition, and nutraceutical products.
• Strategic Context: This is the third protein successfully produced at commercial scale by Burcon, demonstrating the company's technology platform and execution capability.

Notable Quotes

• "With three proteins now successfully produced at commercial scale, Burcon has proven both its technology platform and execution capability. This milestone demonstrates that we can reliably scale innovation into production, creating multiple new revenue streams and expanding our market opportunity." — Kip Underwood, Chief Executive Officer